000 01488 a2200421 4500
005 20250512195012.0
264 0 _c19800928
008 198009s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1980.tb01082.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCadigan, P J
245 0 0 _aCardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cJun 1980
300 _a569-75 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdrenergic beta-Antagonists
_xadverse effects
650 0 4 _aAdult
650 0 4 _aBetaxolol
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aHalf-Life
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aPeak Expiratory Flow Rate
650 0 4 _aPropanolamines
_xadverse effects
650 0 4 _aTime Factors
700 1 _aLondon, D R
700 1 _aPentecost, B L
700 1 _aBianchetti, G
700 1 _aGomeni, R
700 1 _aKilborn, J R
700 1 _aMorselli, P L
773 0 _tBritish journal of clinical pharmacology
_gvol. 9
_gno. 6
_gp. 569-75
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1980.tb01082.x
_zAvailable from publisher's website
999 _c6104591
_d6104591